Market Highlights: The intravascular imaging system is the medical device that detects symptoms in vessels of an artery in Cardiovascular artery diseases. This device allows taking images of blood vessels inside the artery. This system is used in following diseases such as disseminated intravascular coagulation (DIC), blocking of blood vessels due to blood clot or sepsis, heart-related diseases due to coronary blockage, etc. are some of the chronic diseases which require a timely and precise diagnosis. Different types are available in this type of disease used for various detection of disease. The market study is being classified by Type (OCT Endoscopic Imaging System and Hybrid Intravascular Imaging System), by Application (Detection and Diagnosis) and major geographies with country level break-up that includes South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).
Key Players: The prominent players in the Intravascular Imaging System are Abbott (United States), Infraredx (United States), Clarius Mobile health (Canada), Philips Volcano (Netherlands), Xuzhou Kaixin Electronic Instruments(China), Convi medical (Canada), St. Jude Medical (United States), Terumo (Japan), Boston Scientific (United States) and ACIST Medical Systems, Inc (United States).
Major Market Development Highlights On 19th August 2019, Boston Scientific Corporation announced the completion of its acquisition of BTG plc to the previously announced scheme of arrangement. BTG develops and commercializes products used in minimally-invasive procedures targeting cancer and vascular diseases, as well as specialty pharmaceuticals. BTG has three key businesses, the largest of which is its highly-differentiated Interventional Medicine portfolio that encompasses interventional oncology therapeutic technologies for patients with liver and kidney cancers, as well as a vascular portfolio for the treatment of deep vein thrombosis, pulmonary embolism, deep venous obstruction, and superficial venous disease. On 31st July 2018 Infraredx Launches Makoto Intravascular Imaging System and Dualpro IVUS+NIRS Catheter in Japan. Infraredx, Inc., a Nipro company, announced the Japanese launch of the Makoto intravascular imaging system and accompanying Dualpro intravascular ultrasound and near-infrared spectroscopy (IVUS+NIRS) catheter for mapping coronary artery disease. The launch follows a spring 2018 limited market release that included more than 10 hospitals in Japan. In August 2017, the company received approval for the Makoto system and Dualpro catheter from Japan’s Pharmaceuticals and Medical Devices Agency.
Key Questions Answered in the Report What will the Intravascular Imaging System Market size and the growth rate be in Future? What are the key factors driving the Intravascular Imaging System Market? What are the key market trends and macro-economic impacting the growth of the Intravascular Imaging System Market? What are the challenges to market growth? Who are the key vendors in the Intravascular Imaging System Market? What are the market opportunities and threats faced by the vendors in the Intravascular Imaging System Market? Trending factors influencing the market shares of the Players. What are the key outcomes of the five forces analysis of the Intravascular Imaging System Market?
Research Methodology: The top-down and bottom-up approaches are used to estimate and validate the size of the Global Intravascular Imaging System market. In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Intravascular Imaging System market. In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc. Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes Medical Imaging Manufacturers, Pathology Labs, Hospital & Diagnostic center, Academic Centre, Research Organization and Government organization. This helps us to gather the data for the players revenue, operating cycle and expense, profit along with product or service growth etc. Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, Annual reports, press releases etc.